Home > Report on the risk assessment of 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone in the framework of the Council Decision on new psychoactive substances.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Report on the risk assessment of 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone in the framework of the Council Decision on new psychoactive substances. Luxembourg: Office for Official Publications of the European Communities.

[img]
Preview
PDF (risk assessment of 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone) - Published Version
1MB

This report presents the data and findings of the risk assessment on the new psychoactive substance, 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone, that was conducted by the Scientific Committee of the EMCDDA. Concerns over this issociative drug in the European Union led to an assessment of the health and social risks posed by the substance in April 2014.

Methoxetamine is an arylcyclohexylamine substance which is chemically similar to ketamine and PCP and in common with these, has dissociative properties.


Date:May 2014
Pages:78 p.
Publisher:Office for Official Publications of the European Communities
Corporate Creators:European Monitoring Centre for Drugs and Drug Addiction
Place of Publication:Luxembourg
EndNote:View
Accession Number:HRB (Electronic Only)
Subjects:A Drugs and alcohol use, abuse, and dependence > Drugs and alcohol effects and consequences
B Drugs and alcohol substances > CNS stimulants
B Drugs and alcohol substances > New (novel) psychoactive substances
VA Geographic area > Europe

Repository Staff Only: item control page